The site offers readers breaking news about the latest regulations, scientific discoveries in a user-friendly format in English as well as Hindi. There is something for everyone on DrugsControl.
Updated several times a day with Latest news/Research News/Hindi News and feature articles, seven days a week, the site covers all the latest Amendments, discoveries in all fields of the Pharma, Regulation, Price Control, Misleading Advts and applied Pharma. Stories are integrated with photographs and illustrations, links to journals and academic studies, related research and topics, and encyclopedic terms, to provide a wealth of relevant information on almost every Pharma topic.
DrugsControl is best known for showcasing the top Pharma news stories from the world’s leading Food and Drug Administrations and research organizations. These stories are selected from among dozens of press releases and other materials submitted to DrugsControl every day, and then edited to ensure high quality and relevance.
Over the past 17 years, DrugsControl has been linked to by FDAs professional associations and research organizations, reference sources and other information authorities, newspapers, magazines and other news services, and increasingly bloggers and social networking sites such as Facebook, Twitter, Google+, and LinkedIn. DrugsControl enjoys high rankings with popular web search engines such as Google and Yahoo for hundreds of scientifically important keywords, including the word “DrugsControl” for which the site comes up in typically the top three search results.
DrugsControl is the international information source about counterfeit products moving in the market for anti-counterfeiting community, including brand-owners, lawyers, investigators, associations, consultants & officials who are dedicated to controlling the counterfeit goods industry.
For more information, please contact us at:
DrugsControl Media Services,
11/90 Kaveri Path, Mansarovar, JAIPUR-302020
We hope you enjoy DrugsControl and make it one of your regularly visited web sites. We welcome all questions and comments.